US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

Wegovy (semaglutide) is a prescription drug used for weight loss and to reduce the risk of serious cardiovascular issues. Wegovy can interact with some supplements and other medications, such as ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...